Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.00
Bid: 75.80
Ask: 76.40
Change: -1.80 (-2.31%)
Spread: 0.60 (0.792%)
Open: 76.40
High: 76.60
Low: 75.80
Prev. Close: 77.80
AXB Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Purchase of Citibank’s India Consumer Business

30 Mar 2022 13:04

RNS Number : 6260G
Axis Bank Limited
30 March 2022
 

AXIS/CS/CO/697/2021-22

 

March 30, 2022

 

Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") w.r.t. acquisition of business undertakings

 

Dear Sir/ Madam,

 

Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform that, the board of directors of Axis Bank Limited (Axis Bank) at their meeting held today i.e. March 30, 2022 have approved the purchase of the Citibank's India Consumer Business from Citibank N.A. (acting through its branch in India) ("CBNA") and the NBFC Consumer Business from Citicorp Finance (India) Limited ("CFIL"), as going concerns, without values being assigned to individual assets and liabilities to either business, subject to fulfilment of specific conditions and obtaining requisite approvals. Axis Bank has executed, inter alia, business transfer agreements with CBNA ("CBNA BTA") and CFIL ("CFIL BTA") on March 30, 2022.

 

The information required pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, is enclosed herewith as Annexure 1. Also, attached as Annexure 2 is the investor presentation and press release capturing further details about the transaction.

 

We wish to inform you that Axis Bank will host a call with analysts and investors on the above matter at 19.00 P.M. (IST) on March 30, 2022.

 

Conference call Dial in information is as follows:

 

Date

30th March 2022

Time

19.00 P.M. ( IST)

Universal Dial-In numbers

+91 22 6280 1253

+91 22 7115 8154

 

International Toll

HongKong : +852 30186877

Singapore : +65 31575746

UK : +44 2034785524

USA : +1 3233868721

International Toll Free

Hong Kong : 800964448

Singapore : 8001012045

UK : 08081011573

USA : 18667462133

Preregistration Link

Diamond Pass Registration (choruscall.in)

 

The above is for your information and records.

 

Thanking you,

Yours faithfully,

For Axis Bank Limited

 

 

Sandeep Poddar

Company Secretary

Encl: As above

 

 

 

 

 

 

 

 

 

 

 

Annexure 1

Disclosure of information pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI circular No. CIR/CFD/CMD/4/2015 dated 9 September 2015.

 

S. No.

Particulars

Description

1.

Name of the target entity, details in brief such as size, turnover etc.;

1. Citibank N.A. (acting through its branch in India) ("CBNA"): Axis Bank Limited (Axis Bank) proposes to acquire CBNA's entire consumer business in India, including the Credit Cards Business, the Deposits Business, the Wealth Management Business, the Loans Business, the Customer Guarantees Business, the Insurance Distribution Business and the Small Banking Business (collectively the "CBNA Undertaking"), as a going concern, without values being assigned to individual assets and liabilities. The amount of gross revenue of CBNA in India for FY 20-21 was INR 16,15,019 Lacs.[1]

 

2. Citicorp Finance (India) Limited ("CFIL"): Axis Bank proposes to acquire CFIL's consumer business which includes the commercial vehicle and construction equipment asset backed financing facilities, assigned asset backed financing portfolio, personal loans portfolio, servicing of assigned mortgages loan portfolio (collectively the "CFIL Undertaking"), as a going concern, without values being assigned to individual assets and liabilities. The amount of gross revenue of CFIL, on a standalone basis, for FY 20-21 was INR 77,933 Lacs.[2]

2.

Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arms length"

No, the transactions are not related party transactions.

3.

Industry to which the entity being acquired belongs

The proposed transaction is acquisition of the

CBNA Undertaking from CBNA and CFIL Undertaking from CFIL. Both CBNA and CFIL belong to the Banking and Finance Industry.

4.

Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity)

The acquisition of CBNA Undertaking and CFIL Undertaking will help strengthen Axis Bank's retail banking franchise and accelerate Axis Bank's growth ambitions across various consumer banking segments.

5.

Brief details of any governmental or regulatory approvals required for the acquisition

1. CBNA Undertaking - In terms of government or regulatory approvals, the transaction is subject to approval from the Competition Commission of India. Additionally, approval from other governmental authorities may be required for certain transitional services.

 

2. CFIL Undertaking - In terms of government or regulatory approvals, the transaction is subject to approval from the Competition Commission of India. Additionally, approval from other governmental authorities may be required for certain transitional services.

 

In addition to the above, the parties will undertake continuous consultations with the Reserve Bank of India and other relevant governmental authorities as may be required for the implementation of the transactions.

6.

Indicative time period for completion of the acquisition

Subject to the satisfactory completion of the customary and contractual conditions in accordance with the provisions of the CBNA BTA and CFIL BTA, respectively, the transactions are currently anticipated to be completed within 12 months or such other date as may be mutually agreed.

7.

Nature of consideration - whether cash consideration or share swap and details of the same

1. CBNA Undertaking - The entire consideration will be discharged by Axis Bank only in cash.

2. CFIL Undertaking - The entire consideration will be discharged by Axis Bank only in cash.

8.

Cost of acquisition or the price at which the shares are acquired

No shares are being acquired pursuant to the proposed transaction. The cost of acquisition of the CBNA Undertaking and the CFIL Undertaking is INR 12,325 crores.

9.

Percentage of shareholding / control acquired and / or number of shares acquired

Not applicable as no shares are being acquired pursuant to the proposed transaction. The transactions are proposed to be consummated as going concern, without values being assigned to individual assets and liabilities to either business.

10.

Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief)

1. CBNA Undertaking - CBNA is the consumer division of financial services multinational Citigroup. CBNA was founded in 1812 as the City Bank of New York, and later became First National City Bank of New York. CBNA began operations in India over a century ago in 1902 in Kolkata. The amount of CBNA's gross revenue in India for the last three financial years is as below[3]:

· FY 18-19: INR 15,23,784 Lacs;

· FY 19-20: INR 17,70,195 Lacs; and

· FY 20-21: INR 16,15,019 Lacs.

 

2. CFIL Undertaking - CFIL is Citigroup's flagship non-banking finance entity. It was incorporated on May 1, 1997 in India. The amount of CFIL's gross revenue, on a standalone basis, for the last three financial years is as below[4]:

· FY 18-19: INR 96,368 Lacs;

· FY 19-20: INR 83,994 Lacs; and

· FY 20-21: INR 77,933 Lacs.

 

http://www.rns-pdf.londonstockexchange.com/rns/6260G_1-2022-3-30.pdf

 

[1] This figure represents the total income, i.e., interest earned and other income for Citibank N.A, India Branch, as a whole (which includes the CBNA Undertaking as well as other business lines of Citibank N.A., India Branch), as per its audited financials for FY 2021, and is not representative of the gross revenue of the CBNA Undertaking.

 

[2] This figure represents the total income, i.e., interest earned and other income for CFIL, as a whole (which includes the CFIL Undertaking as well as other business lines of CFIL), as per its audited financials for FY 2021, and is not representative of the gross revenue of the CFIL Undertaking.

[3] This figure represents the total income, i.e., interest earned and other income for Citibank N.A, India Branch, as a whole (which includes the CBNA Undertaking as well as other business lines of Citibank N.A., India Branch), as per its audited financials for FY 2019, FY 2020 and FY 2021, and is not representative of the gross revenue of the CBNA Undertaking.

 

[4] This figure represents the total income, i.e., interest earned and other income for CFIL, as a whole (which includes the CFIL Undertaking as well as other business lines of CFIL), as per its audited financials for FY 2019, FY 2020 and FY 2021, and is not representative of the gross revenue of the CFIL Undertaking.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJMMBTMTAJBTT
Date   Source Headline
1st Sep 20177:00 amRNSInformation on Bank's exposure to select accounts
3rd Aug 20179:56 amRNSFinal Terms for issue of 500,000,000 Notes
31st Jul 201712:24 pmRNSPublication of Offering Circular - 28 July 2017
31st Jul 201711:52 amRNSAnnual Report for the Financial Year 2016-17
27th Jul 201711:42 amRNSRe-appointment of Smt Shikha Sharma as MD and CEO
27th Jul 201711:34 amRNSAcquisition
27th Jul 20178:10 amRNSAcquisition
25th Jul 201712:17 pmRNS1st Quarter Results
30th Jun 20171:58 pmRNSQUARTERLY REPORTING-ALLOT. OF EQ. SH. UNDER ESOP
29th Jun 20177:00 amRNSINFORMATION ON BANK'S EXPOSURE TO SELECT ACCOUNTS
28th Jun 20173:14 pmRNSIssue of Debt
15th Jun 20172:28 pmRNSIssue of Debt
15th May 201710:04 amRNSAPPROVAL OF GRANT OF STOCK OPTIONS
26th Apr 20175:10 pmRNSBOARD OUTCOME AXIS BANK LIMITED
26th Apr 20171:21 pmRNSFinal Results
31st Mar 20171:31 pmRNSQUARTERLY REPORTING:ALLOTMENT OF SHARES UNDER ESOP
27th Mar 20173:07 pmRNSAXIS RAISES SENIOR NOTES IN INTERNATIONAL MARKET
22nd Mar 20172:11 pmRNSAXIS RAISES SENIOR NOTES IN INTERNATIONAL MARKET
22nd Mar 201712:51 pmRNSNotice of Results
20th Feb 20177:00 amRNSNews clarification
9th Feb 20179:20 amRNSNews Clarification
2nd Feb 201712:34 pmRNSBank Raises Senior Notes in International Market
19th Jan 20172:56 pmRNS3rd Quarter Results
28th Dec 20167:00 amRNSQUARTERLY REPORTING - ALLOTMENT OF ESOP
19th Dec 20169:12 amRNSNotice of Results
9th Dec 20162:34 pmRNSAcquisition
25th Oct 20161:24 pmRNSResult of Meeting
17th Oct 201612:20 pmRNSREDEMPTION OF US$46,000,000 7.167%CALLABLE HYBRID
27th Sep 20164:35 pmRNSAllotment of Equity Shares under ESOP
21st Sep 20162:39 pmRNSNotice of Results
16th Sep 20163:14 pmRNSAcquisition
12th Aug 201610:23 amRNSREDEMPTION AND CANCELLATION
5th Aug 20168:32 amRNSDate of appointment in terms of RBI approval
22nd Jul 20164:59 pmRNSResult of Meeting
22nd Jul 20161:40 pmRNS1st Quarter Results
22nd Jul 20161:38 pmRNSOutcome of board meeting
5th Jul 20162:29 pmRNSAllotment of Equity Shares under ESOP
27th Jun 20162:25 pmRNSAnnual Report and AGM notice
22nd Jun 201612:25 pmRNSIntimation of Board Meeting
22nd Jun 201612:17 pmRNS1st Quarter Results
1st Jun 20162:03 pmRNSIssue of Debt
31st May 20163:32 pmRNSPress Release issued by the Reserve Bank of India
31st May 20167:00 amRNSPricing Supplement - Issue of Green Bonds
27th May 20162:07 pmRNSIssue of Debt
24th May 20162:19 pmRNSIssue of Debt
24th May 20161:00 pmRNSIncorporation of New Subsidiary
18th May 20163:14 pmRNSAllotment of two senior notes
18th May 201611:09 amRNSOffering Circular
12th May 201610:55 amRNSDirectorate Change
11th May 20161:55 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.